Table 2.
The roles of MIF in PD.
| Authors | Study design | Results |
|---|---|---|
| Schwarz et al. 1998 [36] | PD rat model: female Sprague-Dawley rats weighing 200 ± 250 g were injected twice of 6-OHDA into the right ascending nigrostriatal pathway and the ventral tegmental area | MIF-treated animals showed good survival of tyrosine hydroxylase positive ventral midbrain cells by reducing the number of microglial cells in the grafts. |
| Nicoletti et al. 2011 [37] | PD patients: mean age (years) = 61.7, gender (m/f) = 16/14 Control: mean age (years) = 57.3, gender (m/f) = 13/14 |
MIF serum levels increased in PD patients. |
| Li et al. 2019 [38] | Acute PD animal model: intraperitoneally injecting MPTP (20 mg/kg) into 7-week-old mice (n = 6) at 2-h intervals consecutively for four times Chronic PD animal model: injecting MPTP (15 mg/kg) into 7-week-old mice (n = 6) twice per week for five consecutive weeks SH-SY5Y cells |
MIF increased in MPTP-induced mice as well as MPP+ induced SH-SY5Y cells. MIF siRNA and ISO-1 showed neuroprotective effect in MPP+ induced SY5Y cells by regulating inflammation, apoptosis and autophagy. |
| Cheng J et al. 2020 [39] | PD patients: n = 92 Control (age/sex-matched): n = 87 Mice with microglial deletion of Atg5 were generated by crossing the Atg5 locus floxed mice with Itgam/CD11b-Cre mice |
MIF serum levels increased in PD patients. Inhibition of autophagy led to NLRP3 inflammasome activation in microglia by stimulation of the expression of MIF. |
| Zheng LT 2021 [15] | Microglia cells DA neurons |
MIF selective inhibitor inhibited neuroinflammation and protected DA neurons. |
| Park et al. 2022 [5] | PD mouse models: 2 to 3-month-old C57BL/6 male and female mice with stereotaxic injection of α-syn PFF, AAV-α-syn or MPTP intoxication PAAN/MIF KO male and female mice |
PAAN/MIF genetic depletion and nuclease activity mutant both alleviated neuronal loss and motor dysfunctions in PD animal model. MIF nuclease inhibitor significantly blocked α-syn PFF, AAV-α-syn overexpression or MPTP injection-induced neurodegeneration in vivo. MIF tautomerase inhibitors failed to inhibit MIF nuclease activity and parthanatic cell death. |
| Zhang et al. 2022 [16] | BV-2 cells Neurons |
MIF inhibitors showed unti-neuroinflammatory and neuroprotective effects. |